一个整合的前列腺癌进展的蛋白质组形象
Jichang Zhang1, Keith D Rivera2, Daniela Bossi1
1Institute of Oncology Research, Bellinzona, Ticino, Switzerland; Università della Svizzera italiana, Lugano, Ticino, Switzerland.
Cell reports
|June 15, 2025
概括
这项研究揭示了前列腺癌进展期间的蛋白质组变化,确定USP1抑制和RTK-RAS-MAPK通路作为治疗点. 它提供了关于瘤演变和新治疗策略的见解.
科学领域:
- 在瘤学瘤学.
- 蛋白质组学是指蛋白质组学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌的进展涉及瘤转移和雄激素受体 (AR) 路径改变.
- 了解疾病进化过程中的蛋白质组变化对于确定新的治疗点至关重要.
研究的目的:
- 在前列腺癌进展过程中描述蛋白质丰度和翻译后修饰 (PTMs).
- 识别新的治疗机会和驱动疾病演变的分子机制.
主要方法:
- 利用患者衍生的异种移植模型来追踪蛋白质组变化.
- 分析了前列腺癌进展的不同阶段的蛋白质丰度和PTM.
主要成果:
- 确定USP1抑制作为一种潜在的治疗策略.
- 揭示了受体氨酸激酶 (RTK) -RAS-mitogen-activated protein kinase (MAPK) 途径的早期参与. 发现了受体氨酸激酶 (RTK) -RAS-mitogen活性蛋白激酶 (MAPK) 途径的早期参与.
- 突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
- 在线粒体ATP合成,蛋白质体活性,基因剪接和TGF-β信号传递中观察到与PTM相关的变化.
- 描述了转录因子在疾病进展中的作用.
结论:
- 蛋白质基因分析为前列腺癌的演变提供了洞察力,并提出了新的治疗途径.
- 针对USP1和RTK-RAS-MAPK通路可能有利于前列腺癌治疗.
- 有一个网络资源可用于探索蛋白质组数据.
关键词:
CP: 癌症 癌症 癌症在MAPK路径中.通过乙化处理.抗割的前列腺癌是什么?疾病的进展 疾病的进展血统的可塑性 血统的可塑性前列腺癌是前列腺癌.蛋白质的酸化是蛋白质的酸化.抗抗抑制雄激素受体的耐药性无处不在的无处不在关系更多相关视频
相关概念视频
01:33Proteomics
8.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.0K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K